Artwork
iconShare
 
Manage episode 507300261 series 2652560
Content provided by Lung Cancer Canada. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Lung Cancer Canada or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://staging.podcastplayer.com/legal.
In this episode, Dr. Paul Wheatley-Price is back for another update into all the newest highlights from recent clinical trials for EGFR-positive lung cancer treatments. Dr. Stephen Liu is the Director of Thoracic Oncology and Professor of Medicine at Georgetown University in Washington, DC, and he co-hosts his own podcast with the IASLC, "Lung Cancer Considered". They are also joined by Emi Bossio, a passionate patient advocate who lives with EGFR+ lung cancer and has a number of roles, including as a member on LCC's Board of Directors.
  continue reading

109 episodes